Categories Earnings, Health Care, U.S. Markets News

Chevron Phillips Chemical is looking to acquire Nova Chemicals

Chevron Phillips Chemical Company, a joint venture between Chevron Corp. (NYSE: CVX) and Phillips 66 (NYSE: PSX) is reportedly looking to acquire Canadian plastics maker Nova Chemicals Corp. for over $15 billion, including debt. The news was reported by Reuters and has not yet been officially confirmed.

Nova Chemicals was acquired 10 years ago by Abu Dhabi’s International Petroleum Investment Co., which later merged with Mubadala Investment Co. Mubadala has reportedly been looking to sell Nova for the past couple of months but there is no guarantee it will accept Chevron Phillips’ offer.

The acquisition would be beneficial to Chevron Phillips in expanding its scale and footprint. However none of the companies involved have offered any comment on the matter.  

For the first quarter of 2019, Nova reported revenues of $943 million, down 16% year-over-year. The company generated net profits of $59 million versus a net loss of $555 million in the year-ago quarter.

Chevron’s stock has gained 15% thus far this year while the shares of Phillips 66 have climbed 6% year-to-date. Chevron’s stock was up over 1% in morning hours on Friday while Phillips’ shares were down 0.90%.

We’re on Apple News! Follow us to receive the latest stock market, earnings and financial news at your fingertips.

Most Popular

Microsoft (MSFT) reports higher revenue and profit for Q3 2024

Microsoft Corp. (NASDAQ: MSFT) on Thursday said its third-quarter 2024 earnings increased year-over-year, reflecting strong performance by the tech giant’s main operating segments. Third-quarter revenues came in at $61.86 billion,

GOOG, GOOGL Earnings: All you need to know about Alphabet’s Q1 2024 earnings results

Alphabet Inc. (NASDAQ: GOOG, GOOGL) reported its first quarter 2024 earnings results today. Revenues increased 15% year-over-year to $80.5 billion. Revenue growth was 16% in constant currency. Net income was

MRK Earnings: Merck Q1 2024 profit jumps on 9% revenue growth

Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the first quarter of 2024, aided by an increase in revenues. First-quarter worldwide sales

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top